Merck to Acquire US Biopharma Company SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business
28 APR 2025 | Darmstadt, Germany Purchase price of $47 per share in cash represents an enterprise value of €3.0 ...
Read moreDetails